Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/08/1995 | WO1995023792A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
09/08/1995 | WO1995023791A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same |
09/08/1995 | WO1995023608A1 Antithrombotic agents |
09/08/1995 | CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
09/08/1995 | CA2184112A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same |
09/08/1995 | CA2184111A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
09/08/1995 | CA2180141A1 Antithrombotic agents |
09/08/1995 | CA2160250A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
09/06/1995 | EP0670318A2 Acetamides with analgesic and neuroprotective activity |
09/06/1995 | EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
09/06/1995 | EP0669914A1 Novel isoxazolines as antiinflammatory agents |
09/06/1995 | EP0669824A1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
09/06/1995 | CN1107857A Cyclic amino acid derivativges |
09/06/1995 | CN1107840A Substituted 1-oxo-1,2-dihydro-isochinolinoly-and 1,1-dioro-2H-1,2-benothiazinoylguanidine, preparation, application of same and pharmaceutical containing same |
09/06/1995 | CN1107839A Carbox amide |
09/06/1995 | CN1029683C Process for preparing new steroids substituted at position 10 by a radical including a double or triple bond |
09/05/1995 | US5447959 Vitamin A derivatives |
09/05/1995 | US5447943 Novel benzopyran derivatives |
09/05/1995 | US5447942 Treatment of bronchoconstriction |
09/05/1995 | US5447941 Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes |
09/05/1995 | US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis |
09/05/1995 | US5447928 Antiischemic agents and nervous system disorders |
09/05/1995 | US5447924 Vitamin D analogues |
09/05/1995 | US5447922 α-phosphonosulfinic squalene synthetase inhibitors |
09/05/1995 | US5447919 Sulfated oligosaccharides |
09/05/1995 | US5447721 Solvent extraction of lichen culture; applying to skin; cosmetics |
09/05/1995 | CA2142154A1 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors |
09/05/1995 | CA2010017C Composition for reparation and prevention of fibrotic lesions |
09/05/1995 | CA1336911C Serotonin antagonists |
09/04/1995 | CA2143691A1 Acetamides |
09/03/1995 | CA2143544A1 Pharmaceutical agents for the treatment of myocardial reperfusion injury and myocardial stunning |
09/02/1995 | CA2143603A1 Fatty acid derivatives |
08/31/1995 | WO1995023161A1 Growth arrest homeobox gene |
08/31/1995 | WO1995023139A1 Optically pure 4-aryl-2-hydroxytetronic acids |
08/31/1995 | WO1995022986A1 Fibrin-specific antibody for use as an antithrombotic agent |
08/31/1995 | WO1995022972A1 Rapamycin derivatives |
08/31/1995 | CA2184068A1 Optically pure 4-aryl-2-hydroxytetronic acids |
08/31/1995 | CA2183953A1 Fibrin-specific antibody for use as an antithrombotic agent |
08/31/1995 | CA2183863A1 Growth arrest homeobox gene |
08/30/1995 | EP0669333A1 New imidazopyridine derivatives as angiotensin II antagonists |
08/30/1995 | EP0669322A1 Substituted sulfonamides, process for their preparation and pharmaceutical compositions containing them |
08/30/1995 | EP0668913A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
08/30/1995 | EP0668872A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
08/30/1995 | EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY |
08/30/1995 | EP0668760A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
08/30/1995 | EP0668758A1 Drug delivery device |
08/30/1995 | CN1107473A 4-Arylamino-benzopyran and related compounds |
08/30/1995 | CN1107469A Cyclic amine derivatives |
08/30/1995 | CN1107467A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
08/30/1995 | CN1107364A Pharmaceutical combination |
08/30/1995 | CN1029615C Novel 2,6-Di-alkyl-4-silyl-phenols as antiatherosclerotic agents |
08/30/1995 | CN1029614C Bis-|4-(2,6-di-alkyl) phenol¨ silane derivatives as antiathe-rosclerotic agents |
08/29/1995 | US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation |
08/29/1995 | US5446061 Methods for lowering serum cholesterol |
08/29/1995 | US5446060 Aminoalkyl thienyl ketone derivatives and their use as peripheral vasodilators |
08/29/1995 | US5446046 1,3-dipropyl-8-(3-oxatricyclo(3,1,2,0(2,4-))oct6(7)-Yl)-xanthine used to treat cadiac arrhythmias |
08/29/1995 | US5446039 Treating nervous system and brain disorder, acting as excitatory amino acid antagonist |
08/29/1995 | US5446034 Vitamin D analogues |
08/29/1995 | US5445805 Large potassium bicarbonate crystals and process for the preparation thereof |
08/29/1995 | CA1336835C Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds |
08/29/1995 | CA1336824C Method of safely providing anesthesia or conscious sedation |
08/29/1995 | CA1336817C Angiogenesis inhibitor |
08/25/1995 | CA2143412A1 Imidazopyridine derivatives as angiotensin ii antagonists |
08/24/1995 | WO1995022604A1 Rna editing enzyme and methods of use thereof |
08/24/1995 | WO1995022548A1 Tricyclic spiropiperidines |
08/24/1995 | WO1995022546A1 Intracellular signalling mediators |
08/24/1995 | WO1995022329A1 Agent for prophylaxis and treatment of thromboxane a2-mediated diseases |
08/24/1995 | WO1995022325A1 Compositions containing micronized nebivolol |
08/24/1995 | CA2183562A1 Intracellular signalling mediators |
08/24/1995 | CA2183253A1 Rna editing enzyme and methods of use thereof |
08/24/1995 | CA2182733A1 Tricyclic spiropiperidines |
08/23/1995 | EP0668279A2 6-Azaindole thromboxane synthase inhibitors |
08/23/1995 | EP0668278A1 Adhesion receptor antagonists |
08/23/1995 | EP0668273A1 Derivatives of 1-2-(1H-inden-3-yl)ethyl-4-(naphtalen-1-yl)-piperazin, their preparation and their therapeutical use |
08/23/1995 | EP0668077A1 Compositions containing G-CSF and TNF binding protein |
08/23/1995 | EP0668074A1 Pharmaceutical composition |
08/23/1995 | EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
08/23/1995 | EP0667856A1 Novel vitamin d analogues |
08/23/1995 | EP0667855A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
08/23/1995 | EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
08/23/1995 | EP0667780A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
08/23/1995 | EP0667776A1 Methods and compositions of (+) doxazosin for the treatment of hypertension |
08/23/1995 | EP0667775A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
08/23/1995 | EP0667770A1 Inhibition of tnf production. |
08/23/1995 | CN1107159A Linear adhesion inhibitors |
08/23/1995 | CN1107154A Chloride substituted imidazole derivative |
08/23/1995 | CN1107149A 哌嗪衍生物 Piperazine derivatives |
08/23/1995 | CN1107146A A process for preparing a composition containing benzoheterocycles |
08/23/1995 | CN1107135A Glutaric acid derivatives and preparation thereof |
08/22/1995 | US5444082 3,9-disubstituted-spiro(5.5)undecanes active on the cardiovascular system, process for their preparation and pharmaceutical composition containing same |
08/22/1995 | US5444081 Treatment of hypertension, congestive heart failure, renal failure, glaucoma |
08/22/1995 | US5444080 Hypotensive agents |
08/22/1995 | US5444071 Quinoline derivatives and use thereof as angiotensin II antagonists |
08/22/1995 | US5444068 Imidazopyridine derivatives as angiotensin II receptor antagonists, pharmaceuticals, and treatment of hypertension therewith |
08/22/1995 | US5444056 Aminoalkoxyphenyl derivatives, process for their preparation and compositions containing them |
08/22/1995 | US5444055 17-hydroxyiminomethyl-5-β, 14 β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
08/22/1995 | US5444050 Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa |
08/22/1995 | US5443842 Mixed with isopropyl myristate or palmitate and polyethoxy-lated, hydrogenated castor oils |
08/22/1995 | CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives |
08/20/1995 | CA2142741A1 Adhesion receptor antagonists |